RecruitingPhase 1ketamine

HNC: Human Neural Circuits Electrophysiology During Cognition

NCT ID

NCT05962424

Target Enrollment

120 participants

Start Date

2023-10-05

Est. Completion

2030-09-01

About This Study

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Conditions Studied

Psychiatric Disorder

Interventions

•Ketamine Hydrochloride

Eligibility

Age:18 Years - N/A

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Patient in clinical neuro inpatient units at Stanford Medical Center
* Age \>18 years old
* Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)

Exclusion Criteria:

* Lifetime psychotic disorder
* Pregnant or nursing females
* Prior adverse ketamine response
* Use of ketamine in past 7 days

Study Locations (1)

Stanford University

Palo Alto, California, United States